Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dario Gelevski

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Magnetic Resonance in Chemistry : MRC|April 7, 2021
Towards large-scale steady-state enhanced nuclear magnetization with in situ detectionJohn W Blanchard, Barbara Ripka, Benjamin A Suslick, et al.
Muscle & Nerve|November 8, 2025
Amyotrophic Lateral Sclerosis Clinical Research Site Operations: Emerging Challenges and Potential Solutions From Multiple Sites in the USErica Scirocco, Sarah D Luppino, Matti D Allen, et al.
The New England Journal of Medicine|July 9, 2020
<i>SOD1</i> Suppression with Adeno-Associated Virus and MicroRNA in Familial ALSChristian Mueller, James D Berry, Diane M McKenna-Yasek, et al.
Muscle & Nerve|March 21, 2025
An Expanded Access Protocol of RNS60 in Amyotrophic Lateral SclerosisGrace Addy, Erica Scirocco, Dario Gelevski, et al.
Muscle & Nerve|June 29, 2022
An expanded access protocol of RT001 in amyotrophic lateral sclerosis-Initial experience with a lipid peroxidation inhibitorMegan Yerton, Allison Winter, Anthony Kostov, et al.
Muscle & Nerve|March 17, 2023
Expanded access protocol (EAP) program for access to investigational products for amyotrophic lateral sclerosis (ALS)Megan Yerton, Allison Winter, Dario Gelevski, et al.
Muscle & Nerve|February 25, 2023
Randomized trial of inosine for urate elevation in amyotrophic lateral sclerosisDavid Walk, Katharine Nicholson, Eduardo Locatelli, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 5, 2024
Allogeneic B cell immunomodulatory therapy in amyotrophic lateral sclerosisRuxandra F Sîrbulescu, Katharine Nicholson, Kento Kawai, et al.
Muscle & Nerve|December 19, 2022
Safety and activity of anti-CD14 antibody IC14 (atibuclimab) in ALS: Experience with expanded access protocolDario Gelevski, Grace Addy, Margot Rohrer, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 8, 2026
ALS untangled #83: clenbuterolAdam Burgess, Olivia Allen, Paul Barkhaus, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Magnetic Resonance in Chemistry : MRC|April 7, 2021
Towards large-scale steady-state enhanced nuclear magnetization with in situ detectionJohn W Blanchard, Barbara Ripka, Benjamin A Suslick, et al.
Muscle & Nerve|November 8, 2025
Amyotrophic Lateral Sclerosis Clinical Research Site Operations: Emerging Challenges and Potential Solutions From Multiple Sites in the USErica Scirocco, Sarah D Luppino, Matti D Allen, et al.
The New England Journal of Medicine|July 9, 2020
<i>SOD1</i> Suppression with Adeno-Associated Virus and MicroRNA in Familial ALSChristian Mueller, James D Berry, Diane M McKenna-Yasek, et al.
Muscle & Nerve|March 21, 2025
An Expanded Access Protocol of RNS60 in Amyotrophic Lateral SclerosisGrace Addy, Erica Scirocco, Dario Gelevski, et al.
Muscle & Nerve|June 29, 2022
An expanded access protocol of RT001 in amyotrophic lateral sclerosis-Initial experience with a lipid peroxidation inhibitorMegan Yerton, Allison Winter, Anthony Kostov, et al.
Muscle & Nerve|March 17, 2023
Expanded access protocol (EAP) program for access to investigational products for amyotrophic lateral sclerosis (ALS)Megan Yerton, Allison Winter, Dario Gelevski, et al.
Muscle & Nerve|February 25, 2023
Randomized trial of inosine for urate elevation in amyotrophic lateral sclerosisDavid Walk, Katharine Nicholson, Eduardo Locatelli, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 5, 2024
Allogeneic B cell immunomodulatory therapy in amyotrophic lateral sclerosisRuxandra F Sîrbulescu, Katharine Nicholson, Kento Kawai, et al.
Muscle & Nerve|December 19, 2022
Safety and activity of anti-CD14 antibody IC14 (atibuclimab) in ALS: Experience with expanded access protocolDario Gelevski, Grace Addy, Margot Rohrer, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 8, 2026
ALS untangled #83: clenbuterolAdam Burgess, Olivia Allen, Paul Barkhaus, et al.
Pageof 1